WHO/HAI antibiotic pricing data for treatment of neonatal sepsis by WHO region.

Abstract

<p>Total cost is estimated for the course of treating a 3 kg neonatal child for 10 days. For capsular formulation, the assumption was reconstitution in sterile water. For oral suspension 10% wastage was assumed.</p><p>For vials, a shelf life of 24 hours was assumed for ceftriaxone. The data were from 2001 to 2013, and were not adjusted for inflation.</p>a<p>Data based on national surveys from: AFR (<i>n</i> = 4), AMR (<i>n</i> = 1).</p>b<p>Data based on national surveys from: AFR (<i>n</i> = 8), AMR (<i>n</i> = 2), EMR (<i>n</i> = 9), SEAR (<i>n</i> = 4), WPR (<i>n</i> = 5).</p>c<p>Data based on national surveys from: AFR (<i>n</i> = 15), AMR (<i>n</i> = 9), EMR (<i>n</i> = 13), SEAR (<i>n</i> = 4), WPR (<i>n</i> = 5).</p>d<p>Data based on national surveys from: AFR (<i>n</i> = 15), AMR (<i>n</i> = 9), EMR (<i>n</i> = 13), SEAR (<i>n</i> = 3), WPR (<i>n</i> = 4).</p>e<p>Data based on national surveys from: AFR (<i>n</i> = 0), AMR (<i>n</i> = 1), EMR (<i>n</i> = 0), SEAR (<i>n</i> = 0), WPR (<i>n</i> = 0).</p><p>AFR, Africa; AMR, Americas; EMR, Eastern Mediterranean; SEAR, Southeast Asia; WPR, Western Pacific.</p><p>WHO/HAI antibiotic pricing data for treatment of neonatal sepsis by WHO region.</p